{"id":"https://openalex.org/W3204862279","doi":"https://doi.org/10.1016/j.annonc.2021.08.1038","title":"516MO Phase I/II study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with solid tumor malignancies","display_name":"516MO Phase I/II study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with solid tumor malignancies","publication_year":2021,"publication_date":"2021-09-01","ids":{"openalex":"https://openalex.org/W3204862279","doi":"https://doi.org/10.1016/j.annonc.2021.08.1038","mag":"3204862279"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2021.08.1038","doi":"https://doi.org/10.1016/j.annonc.2021.08.1038","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.08.1038","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.annonc.2021.08.1038","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031059616","display_name":"H. Park","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Park","raw_affiliation_strings":["Oncology Department, Washington University School of Medicine, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, Washington University School of Medicine, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045419282","display_name":"Geoffrey Ira Shapiro","orcid":"https://orcid.org/0000-0002-3331-4095","observed_orcids":["https://orcid.org/0000-0002-3331-4095"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Shapiro","raw_affiliation_strings":["Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100713602","display_name":"Xin Yuan Gao","orcid":"https://orcid.org/0000-0003-0108-6961","observed_orcids":["https://orcid.org/0000-0003-0108-6961"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"X. Gao","raw_affiliation_strings":["Genitourinary Cancers Program, Phase 1 Investigational Program, Massachusetts General Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genitourinary Cancers Program, Phase 1 Investigational Program, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002142386","display_name":"Amit Mahipal","orcid":"https://orcid.org/0000-0002-1111-8333","observed_orcids":["https://orcid.org/0000-0002-1111-8333"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Mahipal","raw_affiliation_strings":["Medical Oncology, Mayo Clinic Cancer Center, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Mayo Clinic Cancer Center, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054238636","display_name":"Jason Scott Starr","orcid":"https://orcid.org/0000-0002-8674-8102","observed_orcids":["https://orcid.org/0000-0002-8674-8102","https://orcid.org/0000-0003-4922-1392"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]},{"id":"https://openalex.org/I4390039324","display_name":"Mayo Clinic Comprehensive Cancer Center (Florida)","ror":"https://ror.org/007q04248","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710","https://openalex.org/I4390039324"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.S. Starr","raw_affiliation_strings":["Oncology, Mayo Clinic Florida, Jacksonville, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Mayo Clinic Florida, Jacksonville, FL, USA","institution_ids":["https://openalex.org/I4210146710","https://openalex.org/I4390039324"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083477114","display_name":"Muhammad Furqan","orcid":"https://orcid.org/0000-0003-3137-2053","observed_orcids":["https://orcid.org/0000-0003-3137-2053"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]},{"id":"https://openalex.org/I4390039339","display_name":"University of Iowa Holden Comprehensive Cancer Center","ror":"https://ror.org/01jhe7086","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I126307644","https://openalex.org/I4390039339"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Furqan","raw_affiliation_strings":["Holden Comprehensive Cancer Center, University of Iowa, Iowa Cita, IA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Holden Comprehensive Cancer Center, University of Iowa, Iowa Cita, IA, USA","institution_ids":["https://openalex.org/I126307644","https://openalex.org/I4390039339"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074582149","display_name":"Parminder Pal Singh","orcid":"https://orcid.org/0000-0002-2851-6805","observed_orcids":["https://orcid.org/0000-0002-2851-6805"]},"institutions":[{"id":"https://openalex.org/I4390039332","display_name":"Mayo Clinic Comprehensive Cancer Center (Arizona)","ror":"https://ror.org/003xpy695","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4390039332"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Singh","raw_affiliation_strings":["Hematology Medical Oncology Department, Mayo Clinic Cancer Center, Phoenix, AR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Medical Oncology Department, Mayo Clinic Cancer Center, Phoenix, AR, USA","institution_ids":["https://openalex.org/I4390039332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011277879","display_name":"Afzal Ahrorov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Ahrorov","raw_affiliation_strings":["Investigational Cancer Therapeutics Department, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Investigational Cancer Therapeutics Department, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009043735","display_name":"D. Hickman","orcid":"https://orcid.org/0009-0005-4417-551X","observed_orcids":["https://orcid.org/0009-0005-4417-551X"]},"institutions":[{"id":"https://openalex.org/I4405268024","display_name":"Aprea Therapeutics, Inc. (United States)","ror":"https://ror.org/05ete2f36","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268024"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Hickman","raw_affiliation_strings":["Clinical, Aprea Therapeutics, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical, Aprea Therapeutics, Boston, MA, USA","institution_ids":["https://openalex.org/I4405268024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057477189","display_name":"Phillip Gallacher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268024","display_name":"Aprea Therapeutics, Inc. (United States)","ror":"https://ror.org/05ete2f36","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268024"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Gallacher","raw_affiliation_strings":["Clinical, Aprea Therapeutics, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical, Aprea Therapeutics, Boston, MA, USA","institution_ids":["https://openalex.org/I4405268024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089274301","display_name":"Eyal C. Attar","orcid":"https://orcid.org/0000-0002-1959-8079","observed_orcids":["https://orcid.org/0000-0002-1959-8079"]},"institutions":[{"id":"https://openalex.org/I4405268024","display_name":"Aprea Therapeutics, Inc. (United States)","ror":"https://ror.org/05ete2f36","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268024"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Attar","raw_affiliation_strings":["Clinical, Aprea Therapeutics, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical, Aprea Therapeutics, Boston, MA, USA","institution_ids":["https://openalex.org/I4405268024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086249998","display_name":"Mark Magdi Awad","orcid":"https://orcid.org/0000-0003-0928-5244","observed_orcids":["https://orcid.org/0000-0003-0928-5244"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Awad","raw_affiliation_strings":["Thoracic Oncology Treatment Center, Dana Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology Treatment Center, Dana Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066217699","display_name":"Satya Das","orcid":"https://orcid.org/0000-0002-7625-1039","observed_orcids":["https://orcid.org/0000-0002-7625-1039"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Das","raw_affiliation_strings":["Medicine, Vanderbilt University Medical Center, Nashville, TN, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Vanderbilt University Medical Center, Nashville, TN, USA,","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113033878","display_name":"Ecaterina E Ileana Dumbrava","orcid":"https://orcid.org/0000-0002-1959-0536","observed_orcids":["https://orcid.org/0000-0002-1959-0536"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E.E. Ileana Dumbrava","raw_affiliation_strings":["Investigational Cancer Therapeutics Department, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Investigational Cancer Therapeutics Department, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":14,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.091,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.43816642,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"32","issue":null,"first_page":"S586","last_page":"S586"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7378000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7378000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.24560000002384186,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apr-246","display_name":"APR-246","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9819999933242798},{"id":"https://openalex.org/keywords/p53-stabilization","display_name":"p53 stabilization","score":0.8809999823570251},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.8560000061988831},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6880000233650208},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8299999833106995},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.9319999814033508},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.9340000152587891},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.847000002861023},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7070000171661377},{"id":"https://openalex.org/keywords/ferroptosis","display_name":"ferroptosis","score":0.8500000238418579},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7580000162124634},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9319999814033508},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.5320000052452087}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9226780533790588},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8368680477142334},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6726711392402649},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6100964546203613},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5396753549575806},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5195058584213257},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5167062282562256},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4312676787376404},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2507775127887726},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.23446348309516907}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2021.08.1038","doi":"https://doi.org/10.1016/j.annonc.2021.08.1038","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.08.1038","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2021.08.1038","doi":"https://doi.org/10.1016/j.annonc.2021.08.1038","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.08.1038","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3171763666","https://openalex.org/W4295062671","https://openalex.org/W4365512155","https://openalex.org/W3030385324","https://openalex.org/W2886811182","https://openalex.org/W3171824834","https://openalex.org/W3103982415","https://openalex.org/W2794307699","https://openalex.org/W2785495519","https://openalex.org/W2891255999"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2021-10-11T00:00:00"}